CERENO SCIENTIFIC AB B (4A1) — Financial Flexibility Index
CERENO SCIENTIFIC AB B (4A1) has a Financial Flexibility Index of 0.28x as of June 2026. Free cash flow of €73.34 Million (operating CF €20.90 Million minus capex €52.44 Million) represents 0% of total liabilities (€261.12 Million). Check CERENO SCIENTIFIC AB B total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CERENO SCIENTIFIC AB B Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for CERENO SCIENTIFIC AB B across 5 annual periods. For the full cash flow conversion analysis, see CERENO SCIENTIFIC AB B cash conversion from operations.
Annual Financial Flexibility Index for CERENO SCIENTIFIC AB B (2021–2025)
Year-by-year free cash flow to debt coverage for CERENO SCIENTIFIC AB B. Explore CERENO SCIENTIFIC AB B cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.45x | €-67.59 Million | €-111.93 Million | €150.08 Million | ▼ -435.8% |
| 2024 | -0.08x | €-18.65 Million | €-103.42 Million | €221.85 Million | ▼ -146.6% |
| 2023 | 0.18x | €12.36 Million | €-36.92 Million | €68.56 Million | ▼ -93.4% |
| 2022 | 2.75x | €38.92 Million | €-18.62 Million | €14.14 Million | ▼ -7.2% |
| 2021 | 2.97x | €31.67 Million | €-13.14 Million | €10.67 Million | — |